Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: The AFFIRM study

G. Folprecht, C. Pericay, M. P. Saunders, A. Thomas, R. Lopez Lopez, J. K. Roh, V. Chistyakov, T. Höhler, Jun Suk Kim, R. D. Hofheinz, S. P. Ackland, D. Swinson, M. Kopp, D. Udovitsa, M. Hall, T. Iveson, A. Vogel, J. R. Zalcberg

Research output: Contribution to journalArticle

34 Citations (Scopus)

Fingerprint Dive into the research topics of 'Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: The AFFIRM study'. Together they form a unique fingerprint.

Medicine & Life Sciences